Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Percent.
The item "Funds-From-Operation-To-Total-Debt" stands at 26.62 percent as of 06/30/2025, the lowest value at least since 03/31/2022, the period currently displayed.
As of the end of Sino Biopharmaceutical Ltd's second quarter, the item "Funds From Operation To Total Debt" stands at 26.62 Percent. This represents a decrease of -8.54 percentage points compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -76.54 percentage points compared to the value the year prior.
The 1 year change in percentage points is -76.54.
The 3 year change in percentage points is -32.80.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Funds From Operation To Total Debt | 905,699,262,464.00 |
![]() | Johnson & Johnson - Funds From Operation To Total Debt | 486,508,953,600.00 |
![]() | AbbVie Inc - Funds From Operation To Total Debt | 399,570,305,024.00 |
![]() | Roche Holding AG - Funds From Operation To Total Debt | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Funds From Operation To Total Debt | 280,205,508,085.11 |